September 10, 2025Scientific ReportsOpen Access

Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Randomized trial shows curcumin improves ASCVD outcomes in type 2 diabetes patients, suggesting beneficial effects.

Curcumin significantly reduces systolic and diastolic blood pressure, improving cardiovascular health outcomes.
Major findings include decreased LDL-C levels and improved ASCVD risk classification, with significant results at P ≤ 0.001 and P = 0.004.
Randomized controlled trial assigned 72 diabetic patients to either curcumin supplementation or standard treatment alone.
Curcumin demonstrates safety and tolerability, with mild side effects reported, highlighting its potential role in diabetes care.

El-Rakabawy et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark